- Home
- BCAT vs TXG Comparison
BCAT vs TXG Comparison
Compare BCAT & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAT
- TXG
- Stock Information
- Founded
- BCAT 2020
- TXG 2012
- Country
- BCAT United States
- TXG United States
- Employees
- BCAT N/A
- TXG N/A
- Industry
- BCAT Finance/Investors Services
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- BCAT Finance
- TXG Industrials
- Exchange
- BCAT Nasdaq
- TXG Nasdaq
- Market Cap
- BCAT 1.5B
- TXG 1.3B
- IPO Year
- BCAT N/A
- TXG 2019
- Fundamental
- Price
- BCAT $15.20
- TXG $12.80
- Analyst Decision
- BCAT
- TXG Buy
- Analyst Count
- BCAT 0
- TXG 12
- Target Price
- BCAT N/A
- TXG $14.13
- AVG Volume (30 Days)
- BCAT 308.8K
- TXG 4.1M
- Earning Date
- BCAT 01-01-0001
- TXG 08-07-2025
- Dividend Yield
- BCAT 9.38%
- TXG N/A
- EPS Growth
- BCAT N/A
- TXG N/A
- EPS
- BCAT 1.43
- TXG N/A
- Revenue
- BCAT N/A
- TXG $624,662,000.00
- Revenue This Year
- BCAT N/A
- TXG N/A
- Revenue Next Year
- BCAT N/A
- TXG $6.06
- P/E Ratio
- BCAT $11.41
- TXG N/A
- Revenue Growth
- BCAT N/A
- TXG N/A
- 52 Week Low
- BCAT $13.67
- TXG $6.78
- 52 Week High
- BCAT $16.38
- TXG $24.76
- Technical
- Relative Strength Index (RSI)
- BCAT 58.84
- TXG 66.48
- Support Level
- BCAT $15.09
- TXG $11.73
- Resistance Level
- BCAT $15.29
- TXG $13.14
- Average True Range (ATR)
- BCAT 0.13
- TXG 0.75
- MACD
- BCAT 0.01
- TXG 0.03
- Stochastic Oscillator
- BCAT 83.62
- TXG 87.24
About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).